Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @uclcancer
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @uclcancer
-
Prikvačeni tweet
Don't miss
@BBCTwo film#WarintheBlood being shown again TONIGHT at 9pm. This extraordinary film focuses on the work of scientists and clinicians at@ucl@UCLH and the amazing patients undergoing groundbreaking ‘first in-human’#immunotherapy trials.https://www.ucl.ac.uk/news/2019/jul/war-blood-film-about-car-t-cell-therapy …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
UCL Life and Medical Sciences
#graduate#OpenDay happening now we’re here to answer your Cancer MSc and cancer research questions until 8pm!pic.twitter.com/Zu34TUErsx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Ahead of
#WorldCancerDay
, don't miss your last chance to see 'War in the Blood' on BBC iPlayer. 
In following two first in-human trial patients, this documentary gives an incredible insight into @UCLCancer's world-leading CAR T-cell research.http://bbc.in/2NIexQtHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Happening Today! Would you like to learn about the graduate courses we have on offer within the School of Life & Medical Sciences? You'll get the chance to meet representatives, students and lecturers from four different faculties
#LifeinMedSci#MadeAtUcl http://bit.ly/31naBKw pic.twitter.com/YS8uEMN9oG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Research co-led by Dr
@kategowers & Prof Sam Janes@lungsforliving@UCLRespiratory, with@sangerinstitute &@CR_UK, has found that quitting smoking can stop further lung damage & allow new, healthy cells to replenish the lining of the airways. https://www.independent.co.uk/news/science/smoking-quitting-lung-cancer-heal-risk-study-science-a9309066.html …@uclmedscipic.twitter.com/hKQiUa9V6EHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
A nice lay summary of our work.... Lung cancer: quitting smoking regrows protective lung cells – new research https://theconversation.com/lung-cancer-quitting-smoking-regrows-protective-lung-cells-new-research-130830?utm_source=twitter&utm_medium=footertwitterbutton … via
@ConversationUK@uclh@Roy_Castle_Lung@RosetreesT@uclcancer@uclmedsciHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
UCLH car t manufacturing team - closed car T cell manufacture on the Miltenyi Prodigy. Posters at EHA/ EBMT
#CART2020 amayacadinanos-garai, letiticia bosshard-Carter, Juliana Dias. Great work ladies!pic.twitter.com/cAdp6GFxz2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
My main
@NIHRresearch PhD study protocol has been published in@BMJ_Open, find it here: https://bmjopen.bmj.com/content/10/1/e033176 …@uclh@UCLHresearch@_CNMAR_#prehabilitation#physiotherapy#myeloma#cancerrehabpic.twitter.com/zydaQH4KRh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Antibody combinations targeting cell surface receptors are a new modality of cancer therapy. Researchers at
@uclcancer explored EGFR trafficking upon treatment with the antibody combination Sym004.#MadeAtUCL#cancerresearchhttps://go.nature.com/2U2ImzfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
So exciting to see our latest UCLRespiratory work with the Wellcome Sanger team published in Nature today. Definitive evidence for a stem cell population in human airways resistant to smoking damage repopulating lungs with cells with no signs of smoking damage after quittingpic.twitter.com/CIJqVdGnK6
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TODAY at 12:00 Prof Ludmil Alexandrov
@ucsdbe is with us to present#SeminarSeries 'The Repertoire of Mutational Signatures in Human Cancer' All welcome. Hosted by@NischalanPhttps://www.ucl.ac.uk/cancer/events/2020/jan/cancer-institute-seminar-series-prof-ludmil-alexandrov …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Registration is now open for the second
#UCLCancerDomain Symposium on Friday 15 May. The event will showcase numerous disciplines for a distinctive take on cancer themes across a range of environmental scales. http://bit.ly/CancerSymp2020 pic.twitter.com/qQryJQTwrU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Clinician-scientists play fundamental roles in cancer research. Now @NatureCancer: Securing the future of the clinician-scientist by@LoiSher@CharlesSwanton@FAndreMD@karen_noble72@Samuel_Bakhoum@chr_reinhardt Dave Tuveson@CSHL Read it here: https://rdcu.be/b0Fvs pic.twitter.com/YltchcKu1i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Thanks to all who attended the UCL/
@wellcometrust Translational Partnership Award launch event this week! To those who couldn't make it - we've got you covered! Read our full event overview on the TRO website for talk highlights and TINs opportunities: http://bit.ly/UCLWTTPAL pic.twitter.com/megvNDaJcN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
So excited to launch the first of the translational education initiatives as part of our
@wellcometrust partnership. Registration now open for the first 2 training events via@UCL_ACO!https://twitter.com/goldie_oz/status/1219662332177133568 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Pleased the review I wrote with David Teachey on How to Treat Paediatric T-ALL & T-LBL is out in
@BloodJournal this week. Great@ChildrensPhila /@GreatOrmondSt collaboration https://ashpublications.org/blood/article/135/3/159/428813/How-I-treat-newly-diagnosed-T-cell-acute … Few key points…
pic.twitter.com/jo9UvKhkyz
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Great talks from BCI's Ioanna Keklikoglou and
@uclcancer's Bart Vanhaesebroeck in the second session of the@CRUKCOLcentre Mouse Models Workshoppic.twitter.com/mj1V9c88sD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Optimal glucocorticoid regimen with abiraterone acetate.
#APCCC19 presentation.@AttardLab@uclcancer discusses - how to maximize steroid therapy with abiraterone acetate.#WatchNow on UroToday. http://bit.ly/2kQmdFo@apccc19pic.twitter.com/o0HRMlzInh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
War in the Blood is being shown again on BBC2 next Monday 20th January at 9pm. If you missed it last year I hope you can watch it. A film about two extraordinary men, one 18 the other 53, taking part in a clinical trial for a potential cure for cancer.pic.twitter.com/nBnpG4fuLS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uclcancer proslijedio/la je Tweet
Registration is open for the next
@UGI_at_UCL symposium taking place on the 12th of Feb at#UCL, organised jointly with@UCLCancerECN: "Cancer Genomes: Methods and Challenges for the Next Decade". Link:http://tinyurl.com/tk5ls25@uclbiosciences@uclcancer#UGIcancer (1/3)pic.twitter.com/6uSE21VwLt
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.